STOCK TITAN

Sera Prognostics Insider Files to Sell Minor 225-Share Lot

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Sera Prognostics, Inc. (SERA) submitted a Form 144 notice covering the planned sale of 225 Class A common shares through Morgan Stanley Smith Barney on 05 Aug 2025. At the indicated aggregate market value of $563, the transaction is de-minimis relative to the company’s 37,672,784 shares outstanding (≈0.0006%).

The seller—identified in subsequent tables as Mansoor Raza Mirza—previously sold 447 shares over the past three months for total gross proceeds of $980. The shares to be sold were acquired via RSU vesting on the planned sale date, implying the disposal is likely routine compensation-related rather than a directional view on the business. The filer affirms possession of no undisclosed material information, satisfying Rule 144 requirements.

Positive

  • None.

Negative

  • Insider disposition: Even though the amount is trivial, insider selling can be perceived as a slight negative signal.

Insights

TL;DR: Tiny insider sale (225 shares) is immaterial; no impact on SERA valuation or float.

The Form 144 signals a prospective sale by Mansoor Raza Mirza amounting to roughly $0.56k. With almost 38 million shares outstanding, dilution or supply pressure is negligible. Past three-month sales were similarly small. The disposition stems from RSU vesting, a routine liquidity event for employees. No new financial, operational, or strategic information is disclosed, and the seller certifies no undisclosed adverse data. Impact: neutral; investors typically disregard such micro-scale sales unless part of a broader pattern.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

How many SERA shares are being sold under this Form 144?

The notice covers 225 Class A common shares.

What percentage of Sera Prognostics' outstanding shares does the sale represent?

Approximately 0.0006% of the 37,672,784 shares outstanding.

When is the planned sale date for the shares?

The filer indicates an approximate sale date of 05 Aug 2025.

Who is the seller named in the filing?

The tables list Mansoor Raza Mirza as the selling shareholder.

What was the method of share acquisition?

Shares were acquired via restricted-stock-unit (RSU) vesting.

Has the seller sold SERA shares recently?

Yes, 447 shares were sold over the past three months for gross proceeds of $980.
Sera Prognostics, Inc.

NASDAQ:SERA

SERA Rankings

SERA Latest News

SERA Latest SEC Filings

SERA Stock Data

88.38M
33.45M
Medical Devices
Services-medical Laboratories
Link
United States
SALT LAKE CITY